FIELD: medicine.
SUBSTANCE: method involves studying mucous membrane bioptates taken from sigmoid region of large intestine. Apical granular cells available in crypts and basal granular cells in epithelial layer of crypts are determined as dysregenerative disorder signs. The former being available and the latter failing, basic preparations dose uptake is prolonged to 1.5-2 months.
EFFECT: enhanced effectiveness of treatment; reduced risk of adverse side effects and complications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING DEGREE OF INFLAMMATORY PROCESS ACTIVITY IN CASE OF NON-SPECIFIC ULCERATIVE COLITIS IN CHILDREN | 2010 |
|
RU2427322C1 |
| METHOD FOR PREDICTING THE FLOW OF INSPECIFIC ULCEROUS COLITIS IN CHILDREN | 2004 |
|
RU2287817C2 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF TERMINAL COLON | 2022 |
|
RU2807235C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR NONSPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE IN CHILDREN | 2007 |
|
RU2366956C2 |
| METHOD OF DETERMINING DEGREE OF SEVERITY OF NON-SPECIFIC ULCERATIVE COLITIS IN CHILDREN | 2008 |
|
RU2383890C1 |
| METHOD OF DETERMINING DEGREE OF NONSPECIFIC ULCER COLITIS ACTIVITY IN CHILDREN | 2009 |
|
RU2391669C1 |
| METHOD FOR TREATING ULCERATIVE COLITIS | 2000 |
|
RU2165758C1 |
| MEDICINE FOR IMMUNOCOMPETENCE ENHANCEMENT | 2007 |
|
RU2349335C2 |
| METHOD OF TREATING PATIENTS WITH ULCERATIVE COLITIS | 2009 |
|
RU2419443C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN ULCERATIVE COLITIS | 2012 |
|
RU2504779C1 |
